2022 Mutational Scanning Symposium - Toronto, ON
The Brotman Baty Institute is co-sponsoring the fifth annual Mutational Scanning Symposium to be held in-person and online June 13 and 14 in Toronto, followed by an online only poster session on June 16th. More information, including registration details, are available here.
A wide range of topics will be discussed in keynote and breakout sessions, including:
- Computational variant effect prediction
- Target identification and resistance
- Germline variation in common diseases, cancer risks, Mendelian disorders and pharmacogenomics
- Sequence/structure/function relationships
- Somatic variation in cancer
“This year’s symposium builds on the success of previous years’ events and will introduce new issues to the arena of precision medicine,” said BBI’s Dr. Doug Fowler, who will deliver one of two keynote addresses. “Participants, either in-person or online, should look forward to interesting insights and observations from leading international scientists.”
In addition to Fowler, some of the leading scientists confirmed to speak are:
- Dr. Clare Turnbull (also a keynote presenter), professor of Translational Cancer Genetics in the Division of Genetics and Epidemiology at the Institute of Cancer Research in London
- Dr. Debora S. Marks, a researcher in computational biology and an Associate Professor of Systems Biology at Harvard Medical School
- Dr. Matthew Hurles, head of human genetics at the Wellcome Sanger Institute and honorary professor of Human Genetics and Genomics at the University of Cambridge
- Dr. Zhenya Ivakine, Scientist, Genetics & Genome Biology at Sick Kids and Assistant Professor, Department of Physiology, at the University of Toronto
Corporate sponsors of the event include: Deep Genomics, Illumina, CIFAR, Octant, Ambry Genetics, and Medicine by Design.
Among the academic co-sponsors are: the Center For The Multiplex Assessment Of Phenotype (C-MAP), a Center of Excellence in Genome Science advancing the promise of the Human Genome Project by interpreting the landscape of human genetic variation; and the Atlas of Variant Effects Alliance, an international collaboration committed to propelling systematic measurements of variant impact on functional elements of human and pathogen genomes.
Organizers are closely monitoring COVID-19 developments. As of April 1, it is assumed the event will proceed in a hybrid format. If circumstances should require moving to an online-only event, information will be available here.